TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Redo Biosolutions AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
494,848
|
399,542
|
448,650 |
| Financial expenses |
4,465
|
8,073
|
5,124 |
| Earnings before taxes |
100,304
|
59,984
|
59,774 |
| Total assets |
620,427
|
561,773
|
550,528 |
| Current assets |
218,804
|
198,937
|
128,833 |
| Current liabilities |
117,489
|
112,913
|
260,630 |
| Equity capital |
464,685
|
392,544
|
209,669 |
| - share capital |
20,169
|
20,532
|
21,566 |
| Employees (average) | 16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
74.9%
|
69.9%
|
38.1% |
| Turnover per employee | 24,971 | ||
| Profit as a percentage of turnover |
20.3%
|
15.0%
|
13.3% |
| Return on assets (ROA) |
16.9%
|
12.1%
|
11.8% |
| Current ratio |
186.2%
|
176.2%
|
49.4% |
| Return on equity (ROE) |
21.6%
|
15.3%
|
28.5% |
| Change turnover |
102,383
|
-19,382
|
143,920 |
| Change turnover % |
26%
|
-5%
|
47% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.